QuartzQtz.com Competitors

Stone Mountain Capital is a private and independent alternative investment boutique based in London, Zurich, Tallinn, UAQ and Dubai providing alternative investment research and solutions to institutional clients around the globe based on extensive cross asset and risk advisory expertise in structuring and capital introduction for hedge funds, private assets and corporate finance. Hedge Funds We are mandated for capital introduction into leading hedge fund managers with solid performance track records, liquidity provision, standardized fund and managed account structures and established AuM across the 4 main strategies: - Credit / Fixed Income - Equity - Tactical Trading - Fund of Hedge Funds (FoF) Private Assets We are mandated for structuring and capital introduction of private asset (private equity / private debt) and corporate finance transactions. In structuring, the factors investability and bankability are the key considerations on behalf of our clients. We focus on alternative structures like partnerships (GP/LP), funds and securitization platforms and on the level of corporation / management holding and project finance / SPV. We cover direct and co-investments in alternative vehicles and firms for the entire capital of debt, mezzanine and equity across the 4 main asset classes and sectors: - Private Credit - Private Equity / Venture Capital - Real Estate - Fintech Stone Mountain Capital has total alternative Assets under Advisory (AuA) of US$ 62.9 bn*. US$ 48.8 bn* is mandated in hedge funds and US$ 14.1 bn* in private assets and corporate finance (private equity, venture capital, private debt, real estate, fintech). Stone Mountain Capital has arranged new capital commitments of US$ 2.03 bn. * As of 14th June 2025 Stone Mountain Capital LTD is authorised and regulated with FRN: 929802 by the Financial Conduct Authority (‘FCA’) in the United Kingdom. www.stonemountain-capital.com/disclaimer. © 2025 Stone Mountain Capital LTD. All rights reserved.

DeBere Capital Partners is a private investment firm focused on high-impact opportunities across life sciences, deep tech, consumer health, and SaaS. We invest directly in the funds and companies we identify, and we represent a portfolio of innovative growth companies, VC and Private Equity funds through strategic partnerships in a placement capacity. We also invest through aligned syndicates, combining corporate finance expertise with strategic capital. Our core interests include breakthrough therapeutics, gene therapy, neurotech, and longevity biotech. In deep tech, we target innovations in Space Technology, AI, neurotechnology, robotics, and next-gen computing. In consumer health, we back brands in fitness, skincare, wellness, and performance. In SaaS, we focus on digital health, telemedicine, and personalized care.

Gardena Capital is an independent asset management company based in London. It manages funds and private accounts and it offers investment consulting services.